Skip to content
Technology Opportunities & Ventures
While focus is on header menu items,
press the down arrow to open sub-menu.

For Innovators

Getting your innovations out into the world and to the people that need them.

In This Section

Tall buildings in New York City next to a busy street

News

News about TOV and NYU’s commercialization successes.

‹ Home › About › News

About

NYU Hosts Inaugural Innovators’ Dinner to Celebrate and Promote Research Commercialization

November 26, 2025 NYU hosted its inaugural Innovators’ Dinner on Thursday, November 21 to recognize and encourage the commercialization of groundbreaking …

Introducing the NYU Innovators’ “Bill of Rights”

New York University’s Technology Opportunities & Ventures (TOV) is excited to publish the Innovators’ “Bill of Rights” as an outline …
Imagenomix Logo

New Startup Imagenomix Launches to Improve Access to Cancer Testing

TOV is excited to announce the launch of Imagenomix, a new startup that aims to deliver rapid and affordable cancer …

New Startup CARA Systems Launches to Improve Diagnosis and Treatment of Aneurysms

TOV is excited to announce the launch of CARA Systems, a new startup developing a dynamic, non-invasive tool that will …
Photo of Heliotrope founders standing next to each other.

New Startup Heliotrope Photonics Inc. Launches to Boost Solar Panel Efficiency

TOV is excited to announce the launch of Heliotrope Photonics Inc., a new startup that’s developing light-shifting thin films to …
Phone and laptop displaying homepage of Technology Innovations & Ventures website

TOV Launches Its New Website

NYU Technology Opportunities & Ventures (TOV) is excited to announce the launch of its brand-new website. The new site will enhance the …
Ultrasight FDA cleared

FDA Grants Clearance for NYU Startup UltraSight’s Cardiac Ultrasound Technology

NYU Startup UltraSight has been granted FDA clearance for its AI-powered ultrasound guidance technology. UltraSight’s AI guidance software assists medical …
Aethon logo

ATP and NYU Langone Health Launch Aethon Therapeutics to Eradicate Drug-Resistant Cancer Cells

Aethon’s HapImmune™ platform, described in a recent publication in the journal Cancer Discovery, unites immunotherapy and targeted therapy. $30M in Series A …
Researcher in a lab

NYU Langone Health and Deerfield Management Launch Amethyst Innovations with Up To $130 Million to Accelerate Commercialization of Biomedical Discoveries

Researchers at NYU Langone will gain access to Deerfield Management’s capital, infrastructure, and specialized resources to help advance novel therapeutics …